SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 147 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 3.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $223,000 | +14.9% | 29,886 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $194,000 | +47.0% | 29,886 | 0.0% | 0.01% | +33.3% |
| Q4 2016 | $132,000 | -5.7% | 29,886 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $140,000 | -28.6% | 29,886 | 0.0% | 0.01% | -25.0% |
| Q2 2016 | $196,000 | +3.2% | 29,886 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $190,000 | +35.7% | 29,886 | +28.8% | 0.01% | +60.0% |
| Q4 2015 | $140,000 | +0.7% | 23,211 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $139,000 | -12.6% | 23,211 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $159,000 | +12.8% | 23,211 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $141,000 | -12.4% | 23,211 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $161,000 | -14.8% | 23,211 | 0.0% | 0.01% | -16.7% |
| Q3 2014 | $189,000 | 0.0% | 23,211 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $189,000 | +48.8% | 23,211 | +43.2% | 0.01% | +50.0% |
| Q1 2014 | $127,000 | – | 16,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |